Metadata from OpenAlexLast checked: Sep 26, 2026

European Journal of Breast Health — Journal Profile & Submission Links

Galenos Publishing House · ISSN-L 2587-0831

Source-backed journal profile with OpenAlex metadata and links to official submission resources for European Journal of Breast Health.

This page provides a source-backed journal profile and links to official submission resources. Journal instructions can change. Always verify article types, formatting, fees, ethics requirements, and submission rules on the official journal website before submitting.

Official links

Publisher
Galenos Publishing House
Country
—
Open access
Yes
Listed in DOAJ
Yes
APC (USD)
—
Works count
533
Cited-by count
4980
OpenAlex 2-year mean citedness
1.75
Quartile
Q2

Catalog scope notes

The European Journal of Breast Health (Eur J Breast Health) is an international, scientific, open access periodical published by independent, unbiased, and double-blinded peer-review principles journal. It is the official publication of the Turkish Federation of Breast Diseases Societies, and the Senologic International Society (SIS) and the National Consortium of Breast Centers is the official supporter of the journal. The European Journal of Breast Health is published quarterly in January, April, July, and October. The publication language of the journal is English. EJBH aims to be a comprehensive, multidisciplinary source and contribute to the literature by publishing manuscripts with the highest scientific level in the fields of research, diagnosis, and treatment of all breast diseases; scientific, biologic, social and psychological considerations, news and technologies concerning the breast, breast care and breast diseases. The journal publishes original research articles, reviews, letters to the editor, brief correspondences, meeting reports, editorial summaries, observations, novel ideas, basic and translational research studies, clinical and epidemiological studies, treatment guidelines, expert opinions, commentaries, clinical trials and outcome studies on breast health, biology and all kinds of breast diseases, and very original case reports that are prepared and presented according to the ethical guidelines. Topics within the Scope of EJBH concerning breast health, breast biology and all kinds of breast diseases: Epidemiology, Risk Factors, Prevention, Early Detection, Diagnosis and Therapy, Psychological Evaluation, Quality of Life, Screening, Imaging Management, Image-guided Procedures, Immunotherapy, molecular Classification, Mechanism-based Therapies, Carcinogenesis, Hereditary Susceptibility, Survivorship, Treatment Toxicities, and Secondary Neoplasms, Biophysics, Mechanisms of Metastasis, Microenvironment, Basic and Translational Research, Integrated Treatment Strategies, Cellular Research and Biomarkers, Stem Cells, Drug Delivery Systems, Clinical Use of Anti-therapeutic Agents, Radiotherapy, Chemotherapy, Surgery, Surgical Procedures and Techniques, Palliative Care, Patient Adherence, Cosmesis, Satisfaction and Health Economic Evaluations.

Catalog source: scimago. This is not a copy of the publisher's author instructions.

Submission & timeline

Submission portal
Information not currently available.
Average review time
Information not currently available.
Acceptance rate
Information not currently available.
Article types accepted
Information not currently available.
Publication frequency
Information not currently available.

General pre-submission checks for medical manuscripts

Generic checklist only — not journal-specific requirements.

  • Confirm scope fit and intended article type on the official journal site.
  • Abstract structure matches the journal's current requirements.
  • Ethics approval and trial registration statements are complete.
  • Informed consent and patient privacy statements are in place.
  • Reporting guideline compliance (e.g. CONSORT, STROBE, PRISMA) as applicable.
  • Reference style and citation limits per official guidelines.
  • Figures and tables meet resolution, labeling, and count limits.
  • Cover letter addresses novelty, fit, and required declarations.
  • Conflicts of interest statement included.
  • Funding statement included.
  • Data availability statement included when required.

FAQ